This approval marks the Oncomine Dx Target Test’s 8th CDx therapy selection indication CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients whose tumors have a HER2 (ERBB2) activating mutations (SNVs & Exon 20 Insertion) in […]
New deal strengthens Congenica’s presence in India CAMBRIDGE, England — Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomic data, today announces a partnership with Avesthagen, a biotechnology major that specialises in predictive, preventive and personalised healthcare through the convergence of food, pharma and population genetics. […]
San Diego, CA – Proteintech Group today announces that it has established a new subsidiary company, Proteintech Genomics, based out of the thriving life sciences hub of San Diego, California. Proteintech Genomics is building out fully optimized and highly multiplexed proteomic assays to enhance multiomic capabilities across a number of spatial and single cell analysis […]
QIAseq Targeted DNA Pro Panels halve library preparation time for sequencing samples New low-input kit for RNA sequencing further expands QIAGEN’s universal NGS portfolio and reduces disposable plastics use by 90% Four million samples have been processed by growing range of QIAseq NGS panels running on any sequencer Hilden, Germany, and Germantown, Maryland — QIAGEN […]
Element Biosciences Inc., developer of the Element AVITI System, a new and disruptive DNA sequencing platform, announced today it will implement no price increases to the entire range of AVITI reagents, including the sequencing kit, the Adept™ and Elevate™ kits. This effort to democratize their technology and make it more broadly available and affordable, will take effect immediately […]
Assay helps detect drug resistant strains of HIV-1 CARLSBAD, Calif. – Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems HIV-1 Genotyping Kit with Integrase, a research use only assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that resist common antiretrovial […]
Speakers will outline critical steps needed to achieve health equity SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that on September 30, its Illumina Genomics Forum (IGF) will feature Bill Gates, co-chair of the Bill & Melinda Gates Foundation, who will deliver a keynote address on […]
New CFO Hire Will Strengthen LI-COR’s Leadership Team Lincoln, NE. LI-COR, a leading developer of environmental and biotech products, is pleased to announce the appointment of Jim Gould as its new Chief Financial Officer. Tom Reslewic, CEO of LI-COR, said “We’re very excited to have Jim on board. His depth of experience, knowledge, and management […]
Ion Torrent Oncomine Myeloid MRD Assays (RUO) are the first NGS-based tests to offer simultaneous DNA and RNA analysis for myeloid MRD assessment CARLSBAD, Calif., August 04, 2022 – Thermo Fisher Scientific today launched a next-generation sequencing (NGS)-based assay for research in myeloid measurable residual disease (MRD). As the first NGS-based tests to support both DNA […]
Company sharpens its focus on the European market by bolstering its team and building upon its successes with existing portfolio companies in Europe. Illumina Ventures, an independently-managed, healthcare-focused venture firm in a strategic partnership with Illumina, today announced the addition of four new members to its European team. Arnaud Autret, PhD, MSc, will be Principal and […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
